Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-004796
Filing Date
2018-01-22
Accepted
2018-01-22 18:24:43
Documents
1
Period of Report
2017-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3254
  Complete submission text file 0001209191-18-004796.txt   4648
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNAVAX TECHNOLOGIES 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710
Business Address
Janssen Robert (Reporting) CIK: 0001580849 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-34207 | Film No.: 18540758